ROSIE Woods first noticed that her son Louie was getting unexplained bruises on his body when he was just six months old.

NICE publishes final draft guidance recommending efanesoctocog alfa as an option for treating and preventing bleeding in ...

Maharashtra haemophilia patients face medicine shortages, forcing travel to Gujarat for treatment, risking health and ...

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft demand for gene therapies among haemophilia patients and physicians.

Haemophilia is a genetic bleeding disorder and hereditary disorder that affects the ability of the body to form blood clots ...

Haemophilia, a rare blood disorder affecting clotting, is one such condition that can manifest early in life. It’s a ...

Dosing is based on the person’s weight and the treatment at list price would cost around £510,000 per year for an adult ...

A long-acting Factor VIII replacement therapy for haemophilia A from Sobi and Sanofi has been recommended for use by the NHS ...

An estimated 7700 people in England have haemophilia A, with around 1900 classified as severe cases where their factor VIII activity level is less than 1%. Current treatments involve factor VIII ...

Haemophilia is a rare genetic bleeding disorder that causes the blood to take a long time to clot because of a deficiency in one or several blood clotting factors. It is almost exclusively found ...

"Louie had a series of blood tests a few weeks later and we were told he had severe haemophilia,” the mum, a marketing consultant from the Isle of Wight," Rosie said. “We were completely ...

Karimnagar: The Haemophilia Society Peddapalli Chapter organised a Continuing Medical Education (CME) programme and ...